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Bleb-related infection is a potentially sight-threatening complication of glaucoma ﬁltration surgery.
Here, we describe its clinical features and management. Blebitis, or stage I infection, is a mild form of
bleb-related infection. The prognosis of blebitis is usually good, unless it has progressed to later stages.
Endophthalmitis, or stage II or stage III infection, however, is a much-advanced stage of the infection and
has a poorer prognosis. For treatment of bleb-related infections, immediate intensive antibacterial
treatment is urgently required.
Copyright  2011, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Filtration surgery is widely employed formedically uncontrolled
glaucoma. With the introduction of antimetabolites such as mito-
mycin C and 5-ﬂuorouracil, the success rate of ﬁltration surgery has
much increased.1 However, several types of late-onset complica-
tions still develop in a signiﬁcant number of cases, which should
be of concern to both patients and ophthalmologists. One of these
is bleb-related infection2 in which bacteria invade through the
ﬁltering bleb and then through the functioning ﬁstula between the
bleb and the anterior chamber, and ﬁnally into the intraocular
tissues. This is a serious complication that can lead to permanent
visual impairment. Bleb-related infection develops in the majority
of cases after trabeculectomy and has become much more common
due to the popularity of this procedure, but it may arise after any
type of ﬁltration surgery. Here, we discuss the clinical features,
incidence, and management of this often serious complication of
glaucoma surgery.
2. Clinical features
2.1. Classiﬁcation
Bleb-related infections are classiﬁed into blebitis and endoph-
thalmitis. In the former, the infection is located predominantly in
the ﬁltering bleb itself whereas, in the latter, the main locus of theogy, Gifu University Graduate
Japan.
e Ophthalmologic Society of Taiwainfection is inside the eyeball. All bleb-related infections start as
a form of blebitis, but not all cases present as blebitis due to its
often-rapid progression to endophthalmitis. Approximately 50%
of cases are diagnosed as blebitis and 50% as endophthalmitis.
Studies by Azuara-Branco and Katz,3 and by Greenﬁeld,4 divided
endophthalmitis into two stages: one characterized by infection
mainly in the anterior chamber and the other involving infection in
the vitreous and retina. They proposed a new classiﬁcation system
of bleb-related infection: stage I for blebitis (Fig. 1), stage II for
endophthalmitis mainly involving the anterior chamber (Fig. 2),
and stage III for endophthalmitis involving the vitreous (Fig. 3). The
Japan Glaucoma Society further subdivided stage III into stage IIIa
(mild vitreous involvement) and stage IIIb (marked vitreous
involvement).5 This stage III subclassiﬁcation is chieﬂy based on the
visibility of the fundus and vitreous opacity detected by B-mode
echography. The subclassiﬁcation is helpful in determining the
initial therapy for stage III infection.
2.2. Signs and symptoms
Bleb-related infection begins with conjunctival hyperemia,
discharge, foreign body sensation, etc., similar to bacterial
conjunctivitis. The bleb shows a purulent, yellowish appearance in
stage I, but the anterior chamber is clear, very few cells are present,
and there is little or no visual impairment. By contrast, stage II is
characterized by a deﬁnite ﬂare, with cells possibly apparent in the
anterior chamber and hypopyon. Deﬁnitive stage III requires
vitreous involvement, which may be mild in the earlier stage (stage
IIIa), as determined by B-mode echography, but rapidly progresses
to themore advanced stage (stage IIIb) unless appropriately treatedn. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Stage I bleb-related infection or blebitis. Mild conjunctival hyperemia is present.
Fig. 3. Stage III bleb-related infection. Thick opacity is detected by B-mode
echography.
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pain and severe visual impairment will usually develop.
2.3. Risk factors
Several risk factors are known to be associated with the devel-
opment of bleb-related infection. 6e11 These include eyes operated
adjunctively with antimetabolites, bleb leakage present or a posi-
tive Seidel test, inferiorly located blebs, avascular blebs, thin-walled
blebs, axial myopia, prolonged use of antibiotics, seasons, history of
intraocular surgeries, etc. An inferiorly located bleb is associated
with a 4- to 8-fold higher incidence of bleb-related infections in
eyes adjunctively treated with antimetabolites. Avascular, thin-
walled blebs, characteristic of antimetabolite-assisted surgery, are
associated with a signiﬁcantly higher risk for bleb-related infection.
Bleb leakage ascertained by Seidel testing is a signiﬁcant risk factor.
Both an apparent leakage and an oozing leakage should be
considered a dangerous complication.
2.4. Bacteriological examinations
Bacteriological examinations are essential for appropriate
treatment of all bleb-related infections, and conjunctival scraping
should be done for blebitis. Intracameral or intravitreal tappingFig. 2. Stage II bleb-related infection. Conjunctival hyperemia, purulent bleb, and ﬁbrin
formation are visible.should be performed to identify the causative agents for endoph-
thalmitis cases, i.e., stage II or stage III infection. If intravitreal
tapping was properly performed, one can expect cases to
be 55e97% culture-positive.12e14 The rate of positive cultures
increases as the stage progresses.
Although a variety of bacteria may be isolated by culturing,
these bacteria may not be the causative agents. Furthermore, the
type of bacteria varies across the stages. Gram-positive bacteria are
the major isolates, with Staphylococcus epidermidis, Staphylococcus
aureus, Corynebacterium, and Streptococcus commonly found in
stage I infection. Stages II and III are most often associated with
Staphylococcus and Streptococcus, and Streptococcus and Entero-
coccus, respectively.
For all isolates, antimicrobial susceptibility should be deter-
mined and the most potent antibiotic agent should be used to
address the infection.
2.5. Prognosis
The prognosis of a bleb-related infection depends primarily
upon its stage and the virulence of the causative bacteria. The
prognosis of a stage I infection is generally good with most patients
maintaining visual acuity and intraocular pressure (IOP) in the
preinfection range. A stage II infection is somewhat worse, but
patients can maintain visual acuity and IOP control in many of the
cases, unless they progress to stage III. The prognosis of a stage III
infection is signiﬁcantly worse, with visual acuity potentially
dropping to the level of handmotion or less, and loss of IOP control,
in approximately half of all cases. Some stage III cases ultimately
may progress to phthisis bulbi or require enucleation.
Any bleb-related infection caused by Streptococcus, coagulase-
positive Staphylococcus, or Gram-negative bacteria has a poor visualTable 1
Staging of bleb-related infection.
Stage Location
of infection
Clinical features Bacterial culture
I Bleb Hyperemia, yellowish bleb Conjunctiva, discharge
II Anterior
chamber
I & cells in anterior chamber
hypopyon (occasionally)
Aqueous humor
IIIa Vitreous II & vitreous opacity (mild) Vitreous humor
IIIb Vitreous II & vitreous opacity (marked) Vitreous humor
Table 2
Management of bleb-related infection adopted from the Collaborative Bleb-related
Infection Incidence and Treatment Study.5
Stage I
dLevoﬂoxacin 0.5% & cefmenoxime 0.5% eye drops, Q 1 h
dOﬂoxacin ophthalmic ointment at bedtime
dSubconjunctival injection of vancomycin (25 mg) & ceftazidime (100 mg)
Stage II
dLevoﬂoxacin & cefmenoxime eye drops, Q 1 h
dOﬂoxacin ophthalmic ointment at bedtime
dIntracameral injection of vancomycin (1 mg) & ceftazidime (2.25 mg)
dSystemic antibiotics if necessary
Stage IIIa
dLevoﬂoxacin & cefmenoxime eye drops, Q 1 h
dOﬂoxacin ophthalmic ointment at bedtime
dIntravitreal injection of vancomycin (1 mg) & ceftazidime (2.25 mg)
dSystemic antibiotics
dCorticosteroid, either systemic or local, may be used after sufﬁcient antibiotic
therapy
Stage IIIb
dLevoﬂoxacin & cefmenoxime eye drops, Q 1 h
dOﬂoxacin ophthalmic ointment at bedtime
dImmediate vitreous surgery with intravitreal irrigation of vancomycin
(100 mg/500 mL) & ceftazidime (200 mg/500 mL)
dSystemic antibiotics
dCorticosteroid, either systemic or local, may be used after sufﬁcient antibiotic
therapy
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a much better prognosis.
3. Incidence
There are several reports on the incidence of bleb-related
infection. The Collaborative Bleb-related Infection Incidence and
Treatment Study,5 a prospective study on bleb-related infection
being conducted by the Japan Glaucoma Society, has determined
that the probability of bleb-related infection following ﬁltering
surgeries with adjunctive mitomycin C was 1.5 0.6% (cumulative
probability standard error) at the 2.5-year follow-up. They also
found no correlationwith the type of conjunctival incision and that
bleb leakagewas signiﬁcantly related to the incidence. According to
other investigators, the incidence associated with trabeculectomy
is 0.2e0.5% without the use of antimetabolites,15,16 1.9e13.0% for
eyes treated with 5-ﬂuorouracil in cases with follow-up of 1e12
years,6,17,18 and 1.5e13.8% in cases using intraoperativemitomycin C
followed for 16 months to 8 years.2,19e22
4. Management
Immediate intensive treatment is urgently required for all bleb-
related infections. Generally, prompt diagnosis and staging is the
ﬁrst course of action, followed by an expeditious bacterial culture.
This is followed by antibacterial therapy comprising a combined
therapy of eye drops, ointment, subconjunctival or intraocular
injection of antibiotics, and systemic antibiotic therapy. Addition-
ally, vitreous surgery is recommended when vitreous involvement
is apparent or aggravated. Corticosteroid, either systemic or local,
may be used after sufﬁcient antibiotic therapy in cases of stage III
progression. The Collaborative Bleb-related Infection Incidence and
Treatment Study has employed a predetermined management
protocol for bleb-related infection (Table 2).5
Patients should be monitored closely. If the ocular condition
becomes worse, appropriate measures should be promptly taken.
This includes additional administration of antibiotics, conﬁrmation
of the antimicrobial spectrum of the current therapy, a change of
the antibiotics if needed, and emergency vitreous surgery.5. Preventive measures
There are several considerations for the prevention of bleb-
related infection. Long-term use of antibiotics changes the ﬂora of
the conjunctival bacteria and brings new antibiotic-resistant
bacteria into existence. Thus, long-term use of antibiotics is not
recommended. Jampel et al10 pointed out that the history of usage
or present use of antibiotics over 4 weeks after surgery was
a signiﬁcant risk factor for bleb-related infection. As stated above,
some conditions are known to be associated with the development
of bleb-related infection: conjunctival leakage, inferiorly located
blebs, etc. In such cases, the preventive use of antibiotics might be
considered, but usually only for a short period.
Patient education is another important consideration. Informa-
tion on bleb-related infection reduces the risk of infection by
patients’ changes in habit and lifestyle, and may also decrease the
risk of poor visual prognosis because patients are more careful with
ocular hygiene and are more likely to seek prompt consultation if
they notice a sign of infection. Periodical consultation with
ophthalmologists is also important. For example, short-term use of
antibiotic therapy might be recommended when conjunctival
leakage is found at consultation.6. Summary
Bleb-related infection is a potentially sight-threatening compli-
cation of glaucoma ﬁltration surgery. Its clinical features and
management have been described here.References
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